Albany molecular research INC - bozik BPN 25203

Ended Awarded Last action

Contract number
75N95019F00089
Awardee
Awarding agency
Obligated
$1,771,111

Award facts

Contract value 100% obligated
$1,771,110.56 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Albany, NY 12212, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00007 · Drug manufacturing and formulatiion program - bozik BPN 25203 -$94,241
Funding Only Action P00006 · To administratively DE-obligate unexpended and expiring fiscal year 2020 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30,… -$193,612
Other Administrative Action P00005 · Dmfp bozik BPN 25203 -$729,864
Change Order P00004 $729,864
Exercise an Option P00003 $500,346
Change Order P00002 $99,898
Exercise an Option P00001 $929,599
Original award $529,120

About this award

The National Institute on Drug Abuse issued a delivery order to Curia Global Inc. on September 10, 2019, under the Drug Manufacturing and Formulation Program (DMFP) IDIQ with a ceiling value of $1,771,110.56.

The DMFP is an IDIQ supporting drug manufacturing and formulation services for the National Institute on Drug Abuse. Place of performance is Albany, NY. The delivery order was priced on a cost-plus-fixed-fee basis and reached ultimate completion on September 12, 2024.

Service Contract Inventory reporting shows the order's labor activity increased substantially in FY2024, its final year. Curia Global invoiced $1.7 million in FY2024 across 5.5 FTEs and 11,326 contractor hours, representing a sharp escalation from $29 thousand invoiced in FY2023 with 0.1 FTEs. The derived government-paid hourly rate in FY2024 was $153.13 per hour. Across the reported fiscal years FY2021 through FY2024, the hourly rate trended upward from $116.92 to $153.13 per hour. Curia Global self-performed all reported work; no subcontractors were reported on SCI filings.

Quick answers

Who was awarded contract 75N95019F00089?

75N95019F00089 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 10, 2019.

How much is contract 75N95019F00089 worth?

The government has obligated $1,771,111 on 75N95019F00089.

Is contract 75N95019F00089 an order under another contract?

Yes. 75N95019F00089 is a delivery order under HHSN271201500005I, an indefinite delivery contract, on Drug Manufacturing and Formulation Program (DMFP).

Was contract 75N95019F00089 competed?

The extent of competition for 75N95019F00089 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award